VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $132,242,000 | -21.5% | 737,989 | -2.6% | 1.81% | -15.5% |
| Q2 2015 | $168,425,000 | +8.5% | 758,038 | -0.4% | 2.14% | +8.3% |
| Q1 2015 | $155,239,000 | +25.3% | 761,163 | -8.8% | 1.98% | +23.7% |
| Q4 2014 | $123,887,000 | -4.1% | 835,030 | -15.3% | 1.60% | -7.3% |
| Q3 2014 | $129,151,000 | -6.3% | 986,238 | -9.5% | 1.73% | -5.6% |
| Q2 2014 | $137,798,000 | -9.5% | 1,090,192 | -5.7% | 1.83% | -15.3% |
| Q1 2014 | $152,195,000 | -4.6% | 1,156,405 | -15.3% | 2.16% | -7.2% |
| Q4 2013 | $159,559,000 | -8.0% | 1,365,417 | -17.8% | 2.33% | -16.4% |
| Q3 2013 | $173,448,000 | – | 1,661,230 | – | 2.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |